The pharmacology of passive cutaneous anaphylaxis in the calf.
D000818:Animals; D000937:Antigen-Antibody Reactions; D001593:Benzyl Compounds / Q000494:pharmacology; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002417:Cattle / Q000276:immunology*; D004205:Cromolyn Sodium / Q000494:pharmacology; D004049:Diethylcarbamazine / Q000494:pharmacology; D005029:Ethylenediamines / Q000494:pharmacology; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007106:Immune Sera; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects*; D011725:Pyridines / Q000494:pharmacology; D012702:Serotonin Antagonists; D014050:Toluene / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D001593:Benzyl Compounds; D005029:Ethylenediamines; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D007106:Immune Sera; D008744:Methylamines; D011725:Pyridines; D012702:Serotonin Antagonists; D062367:ortho-Aminobenzoates; D014050:Toluene; D004205:Cromolyn Sodium; D001920:Bradykinin; D004049:Diethylcarbamazine; D008784:Methysergide